Page last updated: 2024-10-29

isoflurane and Guillain-Barre Syndrome

isoflurane has been researched along with Guillain-Barre Syndrome in 1 studies

Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.

Guillain-Barre Syndrome: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yousif, HY1
Fry, RA1

Other Studies

1 other study available for isoflurane and Guillain-Barre Syndrome

ArticleYear
Anaesthesia for abdominal aneurysm repair in a patient with Guillain-Barré Syndrome.
    Anaesthesia and intensive care, 2007, Volume: 35, Issue:2

    Topics: Abdominal Pain; Aged; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Aortic Aneurysm

2007